Plexiform neurofibroma is a major contributor to morbidity in patients with neurofibromatosis type I (NF1). Macrophages and mast cells infiltrate neurofibroma, and data from mouse models implicate these leukocytes in neurofibroma development. Antiinflammatory therapy targeting these cell populations has been suggested as a means to prevent neurofibroma development. Here, we compare gene expression in Nf1-mutant nerves, which invariably form neurofibroma, and show disruption of neuron–glial cell interactions and immune cell infiltration to mouse models, which rarely progresses to neurofibroma with or without disruption of neuron–glial cell interactions. We find that the chemokine Cxcl10 is uniquely upregulated in NF1 mice that invariably develop neurofibroma. Global deletion of the CXCL10 receptor Cxcr3 prevented neurofibroma development in these neurofibroma-prone mice, and an anti–Cxcr3 antibody somewhat reduced tumor numbers. Cxcr3 expression localized to T cells and DCs in both inflamed nerves and neurofibromas, and Cxcr3 expression was necessary to sustain elevated macrophage numbers in Nf1-mutant nerves. To our knowledge, these data support a heretofore-unappreciated role for T cells and DCs in neurofibroma initiation.
Jonathan S. Fletcher, Jianqiang Wu, Walter J. Jessen, Jay Pundavela, Jacob A. Miller, Eva Dombi, Mi-Ok Kim, Tilat A. Rizvi, Kashish Chetal, Nathan Salomonis, Nancy Ratner
Title and authors | Publication | Year |
---|---|---|
Granulocyte-Macrophage Colony Stimulating Factor Receptor Contributes to Plexiform Neurofibroma Initiation
Pundavela J, Hall A, Dinglasan SA, Choi K, Rizvi TA, Trapnell BC, Wu J, Ratner N |
Cancers | 2025 |
Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas
Helena Mazuelas, Míriam Magallón-Lorenz, Itziar Uriarte-Arrázola, Alejandro Negro, Inma Rosas, Ignacio Blanco, Elisabeth Castellanos, Conxi Lázaro, Bernat Gel, Meritxell Carrió, Eduard Serra |
JCI Insight | 2024 |
STING facilitates recruitment of activated murine CD8 T cells that promote inflammation-driving peripheral nerve tumor initiation and maintenance
Jay Pundavela, Samantha Dinglasan, Melissa Touvron, Sarah Hummel, Liang Hu, Tilat Rizvi, Kwangmin Choi, David Hildeman, Nancy Ratner |
Science advances | 2024 |
Brain injury drives optic glioma formation through neuron-glia signaling.
Chatterjee J, Koleske JP, Chao A, Sauerbeck AD, Chen JK, Qi X, Ouyang M, Boggs LG, Idate R, Marco Y Marquez LI, Kummer TT, Gutmann DH |
Acta Neuropathologica Communications | 2024 |
C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis
Perrino MR, Ahmari N, Hall A, Jackson M, Na Y, Pundavela J, Szabo S, Woodruff TM, Dombi E, Kim MO, Köhl J, Wu J, Ratner N |
Life science alliance | 2024 |
The NF1+/- Immune Microenvironment: Dueling Roles in Neurofibroma Development and Malignant Transformation
White EE, Rhodes SD |
Cancers | 2024 |
NF1-dependent disruption of the blood-nerve-barrier is improved by blockade of P2RY14.
Patritti-Cram J, Rahrmann EP, Rizvi TA, Scheffer KC, Phoenix TN, Largaespada DA, Ratner N |
iScience | 2024 |
The Role of CXCR3 in Nervous System-Related Diseases
Wang F, Guo B, Jia Z, Jing Z, Wang Q, Li M, Lu B, Liang W, Hu W, Fu X |
Mediators of Inflammation | 2024 |
Leveraging Neural Crest-Derived Tumors to Identify NF1 Cancer Stem Cell Signatures
Khan S, Alson D, Sun L, Maloney C, Sun D |
Cancers | 2024 |
Contemporary Approach to NF1-Associated Malignant Peripheral Nerve Sheath Tumors
Hirbe AC, Dehner CA, Dombi E, Eulo V, Gross AM, Sundby T, Lazar AJ, Widemann BC |
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting | 2024 |
Basement membrane proteins in neurofibroma extracellular matrix characterize tumor development and treatment response to MEK inhibitor
Chunhui Jiang, Ashwani Kumar, Ze Yu, Tracey Shipman, Yong Wang, Renee McKay, Chao Xing, Lu Q. Le |
Journal of Clinical Investigation | 2023 |
Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma.
Takashima Y, Hamano M, Yoshii K, Hayano A, Fukai J, Iwadate Y, Kajiwara K, Hondoh H, Yamanaka R |
International Journal of Clinical Oncology | 2023 |
Neurofibromin and suppression of tumorigenesis: beyond the GAP
J Mo, S Moye, R McKay, L Le |
Oncogene | 2022 |
P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosis
J Cram, J Wu, R Coover, T Rizvi, K Chaney, R Ravindran, J Cancelas, R Spinner, N Ratner |
eLife | 2022 |
Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1
C Anastasaki, J Mo, J Chen, J Chatterjee, Y Pan, S Scheaffer, O Cobb, M Monje, L Le, D Gutmann |
Nature Communications | 2022 |
Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment
Leah J Kershner, Kwangmin Choi, Jianqiang Wu, Xiyuan Zhang, Melissa Perrino, Nathan Salomonis, Jack Shern, Nancy Ratner |
JCI Insight | 2022 |
The role of CXCR3 and its ligands in cancer
Wang X, Zhang Y, Wang S, Ni H, Zhao P, Chen G, Xu B, Yuan L |
Frontiers in Oncology | 2022 |
A Translational Approach to Spinal Neurofibromatosis: Clinical and Molecular Insights from a Wide Italian Cohort
Paterra R, Bettinaglio P, Borghi A, Mangano E, Tritto V, Cesaretti C, Schettino C, Bordoni R, Santoro C, Avignone S, Moscatelli M, Melone MA, Saletti V, Piluso G, Natacci F, Riva P, Eoli M |
Cancers | 2022 |
Pharmacological Approaches in Neurofibromatosis Type 1-Associated Nervous System Tumors
O Rababh, A Gharaibeh, A Al-Ramadan, M Ismail, J Shah |
Cancers | 2021 |
Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression
D Sun, XP Xie, X Zhang, Z Wang, SF Sait, SV Iyer, YJ Chen, R Brown, DR Laks, ME Chipman, JF Shern, LF Parada |
Cell Stem Cell | 2021 |
Translating current basic research into future therapies for neurofibromatosis type 1
JP Brosseau, CP Liao, LQ Le |
British Journal of Cancer | 2020 |
Cdkn2a Loss in a Model of Neurofibroma Demonstrates Stepwise Tumor Progression to Atypical Neurofibroma and MPNST
KE Chaney, MR Perrino, LJ Kershner, AV Patel, J Wu, K Choi, TA Rizvi, E Dombi, S Szabo, DA Largaespada, N Ratner |
Cancer research | 2020 |
After Nf1 loss in Schwann cells, inflammation drives neurofibroma formation
JS Fletcher, J Pundavela, N Ratner |
2019 |